News Daily News Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed Caitlin E. Cox July 07, 2016
News Daily News Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients Yael L. Maxwell July 05, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016
News Daily News A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease Todd Neale June 16, 2016
News Daily News Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage Michael O'Riordan June 14, 2016
News Daily News Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents Michael O'Riordan June 06, 2016
News Daily News Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis Michael O'Riordan June 06, 2016
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes Michael O'Riordan April 25, 2016
News Daily News Same-Day Discharge After PCI Is Safe, With Benefits for Patients and Hospitals: Review Todd Neale April 01, 2016
News Daily News Alta hospitalaria el mismo día después de someterse a PCI es segura y beneficia a los pacientes y a los hospitales: Revisión Todd Neale April 01, 2016
News Daily News Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES Yael L. Maxwell March 30, 2016
News Daily News Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF Yael L. Maxwell March 30, 2016
News Daily News AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis Michael O'Riordan March 30, 2016